Reaction

Electrocardiogram St Segment Depression reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,181 reports · 59 co-occurring drugs

As of the last recalculation, Electrocardiogram St Segment Depression appears in 2,181 FAERS reports alongside 59 co-occurring drug terms. The strongest observed disproportionality signal is SEVOFLURANE (PRR 51.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Sevoflurane4451.551.8
Rocuronium Bromide3327.127.2
Norepinephrine2825.325.4
Atropine2124.424.5
Norepinephrine Bitartrate3523.623.6
Atropine Sulfate2623.223.3
Propofol8322.522.5
Digoxin15221.721.7
Adrenalinum7417.617.6
Midazolam Hydrochloride4415.915.9
Midazolam4015.415.4
Theophylline1815.115.1
Theophylline Anhydrous1814.014.0
Cefazolin1313.713.7
Basiliximab1613.113.1
Epinephrine8512.912.9
Posaconazole Delayed-Release1311.411.4
Cefazolin Sodium1411.211.2
Isosorbide Dinitrate209.99.9
Piperacillin And Tazobactam139.89.8
Tranexamic Acid99.79.7
Calcium Gluconate129.69.6
Valganciclovir Hydrochloride Powder,129.49.4
Fentanyl Citrate168.68.6
Isosorbide Mononitrate177.97.9
Sodium Bicarbonate197.97.9
Sodium Bicarbonate Injection,197.97.9
Piperacillin Sodium And Tazobactam Sodium167.87.8
Posaconazole137.77.7
Nilotinib237.57.5
Nitroglycerin417.47.4
Dextrose107.37.3
Bupivacaine77.27.2
Dextrose Monohydrate107.27.2
Valganciclovir147.17.1
Valganciclovir Hydrochloride147.17.1
Nicotine Polacrilex Mini117.07.0
Nicotine Polarilex117.07.0
Metolazone86.86.8
Clopidogrel Bisulfate696.66.6
Quetiapine Fumarate206.56.5
Fentanyl656.56.5
Mesna Injection55.85.8
Fluorouracil Cream, 0.5%455.75.7
Meropenem195.75.7
Mesna55.75.7
Fluorouracil455.65.6
Cisplatin374.64.6
Ticagrelor154.54.5
Linezolid144.54.5
Oxaliplatin344.44.4
Capecitabine404.24.2
Iohexol33.53.5
Agalsidase Beta33.13.1
Minoxidil Foam 5% (Womens)102.92.9
Ethyl Alcohol82.82.8
Carfilzomib82.72.7
Minoxidil102.12.1
Romosozumab-Aqqg32.12.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.